Vesicoureteral reflux (VUR) potentially leads to renal damage, scarring, and eventually end-stage renal disease. Endoscopic treatment is well tolerated in children, it has reduced costs, and it effectively prevents urinary tract infections (UTIs), while avoiding long term antibiotics use.
Zambaiti, E., Sergio, M., Di Pace, M.R., Casuccio, A., & Cimador, M. (2020). The fate of implant after endoscopic injection of dextranomer/hyaluronic acid in vesicoureteral reflux: time to partial reabsorption and stabilization. JOURNAL OF PEDIATRIC UROLOGY [10.1016/j.jpurol.2019.12.010].
The fate of implant after endoscopic injection of dextranomer/hyaluronic acid in vesicoureteral reflux: time to partial reabsorption and stabilization
Zambaiti, ElisaWriting – Original Draft Preparation
;Sergio, MariaInvestigation
;Di Pace, Maria RitaInvestigation
;Casuccio, AlessandraMethodology
;Cimador, Marcello
Writing – Review & Editing
2020
Abstract
Vesicoureteral reflux (VUR) potentially leads to renal damage, scarring, and eventually end-stage renal disease. Endoscopic treatment is well tolerated in children, it has reduced costs, and it effectively prevents urinary tract infections (UTIs), while avoiding long term antibiotics use.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
fate of implant.pdf
Solo gestori archvio
Tipologia:
Pre-print
Dimensione
549.56 kB
Formato
Adobe PDF
|
549.56 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
